Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

N-nitrosoethylenethiourea

Known as: NETU 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Background The objective was to evaluate the cost-effectiveness of NEPA, an oral fixed combination netupitant (NETU, 300 mg) and… 
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
2017
2017
OBJECTIVES Breast cancer (BC) patients represent a high-risk population for experiencing chemotherapy-induced nausea and vomiting… 
2016
2016
PurposeAntiemetic guidelines recommend co-administration of targeted prophylactic medications inhibiting molecular pathways… 
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
2014
Highly Cited
2014
In this multinational, phase III study, the safety and efficacy of NEPA, a convenient, fixed-dose antiemetic combination of… 
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
2014
2014
9502 Background: Antiemetic guidelines recommend co-administration of targeted prophylactic medications aimed at inhibiting… 
2014
2014
169 Background: The introduction of NK1 receptor antagonists (RAs) improved the control of chemotherapy-induced nausea and… 
1968
1968
This case study demonstrated the use of slide projection as an alternative to imaginal stimulus presentation in the systematic…